Measurement of urinary estrogen metabolites using a monoclonal enzyme- linked immunoassay kit: Assay performance and feasibility for epidemiological studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 9, 1996, Pages 727-732

  Chen, Chu ^a   Malone, Kathleen E ^a,b   Prunty, JoAnn ^a   Daling, Janet R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTROGEN DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN URINE LEVEL; FEMALE; HUMAN; MENSTRUAL CYCLE; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; RELIABILITY; SEX HORMONE DETERMINATION; URINALYSIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; ESTROGENS; ESTROGENS, CATECHOL; EVALUATION STUDIES; FEASIBILITY STUDIES; FEMALE; FOLLICULAR PHASE; HUMANS; HYDROXYESTRONES; LUTEAL PHASE; MENSTRUAL CYCLE; MIDDLE AGED; PREMENOPAUSE; REAGENT KITS, DIAGNOSTIC; TIME FACTORS;

EID: 0029787237     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kelsey, J. L. A review of the epidemiology of human breast cancer. Epidemiol. Rev., 1: 74-109, 1979.
2. Kelsey, J. L., and Berkowitz, G. S. Breast cancer epidemiology. Cancer Res., 48: 5615-5623, 1988.
3. Boyle, P., and Leake, R. Progress in understanding breast cancer: epidemiological and biological interactions. Breast Cancer Res. Treat., 11: 91-112, 1988.
4. Henderson, B. E., Ross, R., and Bernstein, L. Estrogens as a cause of human cancer. Cancer Res., 48: 246-253, 1988.
5. Kelsey, J. L., and Gammon, M. D. Epidemiology of breast cancer. Epidemiol. Rev., 12: 228-240, 1990.
6. Adami, H. O., Adams, G., Boyle, P., Swertz, M., Lee, N. C, Lund, E., Miller, A. B., Olsson, H., Steele, M., Trichopoulos, D., and Tulinius, H. Breast cancer etiology. Int. J. Cancer., 5: (Suppl.): 22-39, 1990.
7. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., Bradlow, H. L., and Fishman, J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. USA, 79: 3047-3051, 1982.
8. Fishman, J., Schneider, J., Hershcopf, R. J., and Bradlow, H. L. Increased estrogen-16α-hydroxylase activity in women with breast and endometrial cancer. J. Steroid Biochem., 20: 1077-1081, 1984.
9. Swaneck, G. E., and Fishman, J. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA, 85: 7831-7835, 1988.
10. Adlercreutz, H., Gorbach, S. L., Goldin, B. R., Woods, M. N., Dwyer, J. T., and Hamalainen, E. Estrogen metabolism and excretion in Oriental and Caucasian women. J. Natl. Cancer Inst., 86: 1076-1082, 1994.
11. Martucci, C. P., and Fishman, J. Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion. Endocrinology, 105: 1288-1292, 1979.
12. Schneider, J., Hugh, M. M., Bradlow, H. L., and Fishman, J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259: 4840-4845, 1984.
13. Vanderwalle, B., and Lefebvre, J. Opposite effects of estrogen and catechol estrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol. Cell. Endocrinol., 61: 239-246, 1989.
14. Fishman, J., and Martucci, C. Biological properties of 16α-hydroxyestrone: implications in estrogen physiology and pathophysiology. J. Clin. Endocrinol. & Metab., 51: 611-615, 1980.
15. Ikegawa, S., Lahita, R., and Fishman, J. Concentration of 16α-hydroxyestrone in human plasma as measured by a specific RIA. J. Steroid Biochem., 18: 329-332, 1983.
16. Yu, S. C., and Fishman, J. Interaction of histones with estrogens. Covalent adduct formation with 16α-hydroxyestrone. Biochemistry, 24: 8017-8021, 1985.
17. Miyairi, S., Ichikawa, T., and Nambara, T. Structure of the adduct of 16α-hydroxyestrone with a primary amine: evidence for the Heyns rearrangement of steroidal D-ring α-hydroxyimines. Steroids, 56: 361-366, 1991.
18. Telang, N. T., Narayanan, R., Bradlow, H. L., and Osborne, M. P. Coordinated expression of intermediate biomarkers for tumorigenic transformation in ras-transfected mouse mammary epithelial cells. Breast Cancer Res. Treat., 18: 155-163, 1991.
19. Bradlow, H. L, Hershcopf, R. J., Martucci, C. P., and Fishman, J. Estradiol 16 α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA, 82: 6295-6299, 1985.
20. Adlercreutz H., Fotsis, T., Hockerstedt K., Hamalainen, E., Bannwart, C., Bloigu, S., Valtonen, A., and Ollus, A. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J. Steroid Biochem., 34: 527-530, 1989.
21. Lemon, H. M., Heidel, J. W., and Rodriguez-Sierra, J. F. Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer (Phila.), 69: 457-465, 1992.
22. Michnovicz, J. J., Naganuma, H., Hershcopf, R. J., Bradlow, H. L., and Fishman, J. Increased urinary catechol estrogen excretion in female smokers. Steroids, 52: 69-83, 1988.
23. Klug, T. L., Bradlow, H. L., and Sepkovic, D. W. Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine. Steroids, 59; 648-655, 1994.
24. Sepkovic, D. W., Bradlow, H. L., Ho, G., Hankinson, S. E, Long, L., Osborne, M. P., and Fishman, J. Estrogen metabolite ratios and risk assessment of hormone-related cancers. Assay validation and prediction of cervical cancer risk. Ann. NY Acad. Sci., 768: 312-316, 1995.